MedPath

Binaural Sound for Remimazolam Maintenance

Not Applicable
Recruiting
Conditions
Uterine Myoma
General Anesthesia
Prostate Cancer Stage
Interventions
Procedure: Binaural sound
Registration Number
NCT06497283
Lead Sponsor
Gangnam Severance Hospital
Brief Summary

It is important to decrease the remifentanil dose for general anesthesia maintenance when using remimazolam. We will evaluate the effect of binaural sound on general anesthesia maintenance with remimazolam infusion.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
72
Inclusion Criteria
  1. Patients scheduled for general anesthesia
  2. Patients aged 20-60
  3. Patients with American Society of Anesthesiologist physical status classification 1-2
  4. Patients with ideal body weight 50-80 kg
Exclusion Criteria
  1. Patients with hearing disability
  2. Patients using opioids or sedatives in 1 week
  3. Patients who are dependent for alcoholics or drugs
  4. Patients with hypersensitivities to remimazolam or remifentanil
  5. Patients with arrhythmia, cardiovascular disease, heart failure, or hypovolemia
  6. Patients with liver failure

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
I (Binaural)Binaural soundBinaural sound using earphone will be applied.
II (Placebo)Binaural soundOnly headphone without sound will be applied.
Primary Outcome Measures
NameTimeMethod
Intraoperative remifentanil doseAt anesthesia day 0

Intraoperative remifentanil dose will be measured at anesthesia day 0.

Secondary Outcome Measures
NameTimeMethod
Intraoperative remimazolam doseAt anesthesia day 0

Intraoperative remimazolam dose will be measured at anesthesia day 0.

ElectroencephalographyAt anesthesia day 0

The relative power of alpha, beta, delta, gamma, and theta band in electroencephalography will be measured at anesthesia day 0.

Pain score (0:no pain, 10:maximal pain)At anesthesia day 0 and 1

Pain score (0:no pain, 10:maximal pain) will be measured at anesthesia day 0 and 1.

Trial Locations

Locations (1)

Gangnam Severance Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath